TNF Pharmaceuticals, Inc. (TNFA) — Net Asset Quality Index
TNF Pharmaceuticals, Inc. (TNFA) has a Net Asset Quality Index of 67.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $17.15 Million minus total liabilities of $5.55 Million yields net assets of $11.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check TNF Pharmaceuticals, Inc. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
TNF Pharmaceuticals, Inc. Net Asset Quality Index Over Time (2004–2024)
This chart shows how TNF Pharmaceuticals, Inc.'s Net Asset Quality Index has evolved across 21 annual periods from 2004 to 2024. As of June 2025, the index stands at 67.6%, representing net assets of $11.60 Million against total assets of $17.15 Million USD. See TNF Pharmaceuticals, Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for TNF Pharmaceuticals, Inc. (2004–2024)
The table below presents the year-by-year Net Asset Quality Index for TNF Pharmaceuticals, Inc. from 2004 to 2024, covering 21 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see TNFA market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 68.7% | $14.72 Million | $21.42 Million | $6.70 Million | ▼ -2.8 pp |
| 2023 | 71.5% | $12.77 Million | $17.86 Million | $5.09 Million | ▼ -12.3 pp |
| 2022 | 83.8% | $14.70 Million | $17.54 Million | $2.84 Million | ▼ -11.5 pp |
| 2021 | 95.3% | $23.65 Million | $24.81 Million | $1.17 Million | ▲ +1.4 pp |
| 2020 | 93.9% | $34.58 Million | $36.84 Million | $2.26 Million | ▲ +7.9 pp |
| 2019 | 85.9% | $9.36 Million | $10.88 Million | $1.53 Million | ▲ +11.2 pp |
| 2018 | 74.7% | $5.83 Million | $7.81 Million | $1.97 Million | ▼ -6.2 pp |
| 2017 | 80.9% | $7.55 Million | $9.34 Million | $1.79 Million | ▲ +14.3 pp |
| 2016 | 66.6% | $3.39 Million | $5.09 Million | $1.70 Million | ▼ -13.2 pp |
| 2015 | 79.8% | $6.60 Million | $8.27 Million | $1.67 Million | ▼ -9.1 pp |
| 2014 | 88.9% | $14.81 Million | $16.65 Million | $1.84 Million | ▲ +21.1 pp |
| 2013 | 67.8% | $4.12 Million | $6.08 Million | $1.95 Million | ▲ +0.8 pp |
| 2012 | 67.1% | $4.30 Million | $6.42 Million | $2.11 Million | ▼ -22.5 pp |
| 2011 | 89.6% | $6.17 Million | $6.88 Million | $714.78K | ▲ +6.1 pp |
| 2010 | 83.5% | $6.45 Million | $7.72 Million | $1.27 Million | ▼ -2.7 pp |
| 2009 | 86.2% | $7.18 Million | $8.33 Million | $1.15 Million | ▼ -5.0 pp |
| 2008 | 91.2% | $10.28 Million | $11.27 Million | $996.00K | ▲ +97.4 pp |
| 2007 | -6.3% | $-443.38K | $7.06 Million | $7.50 Million | ▲ +82.6 pp |
| 2006 | -88.9% | $-2.67 Million | $3.00 Million | $5.67 Million | ▼ -126.8 pp |
| 2005 | 37.9% | $3.12 Million | $8.24 Million | $5.11 Million | ▲ +226.5 pp |
| 2004 | -188.6% | $-2.79 Million | $1.48 Million | $4.28 Million | — |